LEXINGTON, KY (Kentucky Space PR) — Kentucky Space LLC, in partnership with the Center for Regenerative and Developmental Biology at Tufts University, announced today an upcoming mission, via a SpaceX launch vehicle to the International Space Station (ISS) on December 16, 2014, involving an important exomedicine experiment.
Exomedicine involves the research, development and commercialization of biomedical solutions in the microgravity environment of space for applications on Earth.
This mission, to be launched from the Kennedy Space Center in Florida, will analyze the
regeneration mechanisms of planarian flatworms in the microgravity environment (and absence of a geomagnetic field) of space. This experiment is a critical step in a specific regenerative medicine research and commercial pathway being pursued by the parties.